HK-listed pharmaceuticals jumbled today. WUXI series snapped the losing streak and bounced back. Blue-chip WUXI APPTEC (02359.HK)  +4.250 (+7.066%)    Short selling $72.12M; Ratio 26.987%   and WUXI BIO (02269.HK)  +1.300 (+5.702%)    Short selling $154.68M; Ratio 25.091%   ticked up 4.3% and 1.7% to $$42.75 and $14.68. WUXI XDC (02268.HK)  +2.200 (+6.019%)    Short selling $8.42M; Ratio 8.375%   regained 6.3% at $16.6.

REMEGEN (09995.HK)  +3.350 (+8.804%)    Short selling $7.18M; Ratio 5.779%   jumped up 8.3% to $29.9. BRII-B (02137.HK)  +0.140 (+7.179%)   reverted up 6.2% to $1.03. VIVA BIOTECH (01873.HK)  +0.060 (+4.082%)   rebounded 5.9% to $0.54.

Related NewsCiti: WUXI APPTEC 1Q25 Results Beat w/ Stellar TIDES Biz Growth
UNITED LAB (03933.HK)  +0.040 (+0.288%)    Short selling $13.01M; Ratio 22.821%   , which had issued a positive profit alert last Friday, peaked at an over-12-year high $9.88, and last traded at $9.7, up 4.5%.

SINOPHARM (01099.HK)  -0.380 (-2.072%)    Short selling $23.65M; Ratio 19.505%   , IMMUNEONCO-B (01541.HK)  +0.120 (+1.920%)    Short selling $195.10K; Ratio 3.092%   and CANSINOBIO (06185.HK)  -0.450 (-1.325%)    Short selling $394.55K; Ratio 2.122%   gained more than 1%-2%.

However, SIRNAOMICS-B (02257.HK)  0.000 (0.000%)   tumbled 20% to $8.044. It had earlier announced that 99,500 shares of the company held by an executive director were forced to be sold.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-05-02 16:25.)

Related NewsG Sachs Lifts WUXI APPTEC's TP to $74.9, Rating Neutral